Tag Archives: Cannabis stocks

CannPal Commences Phase 1B Study for Lead Drug Candidate CPAT-01D

Animal health company CannPal Animal Therapeutics Limited (ASX:CP1) (“CannPal” or “the Company”) is pleased to announce that it has commenced Phase 1B of the Pharmacokinetic and Safety study for CPAT-01D, a cannabis-derived veterinary medicine being developed as a pain control in dogs. Key Highlights Commenced Phase 1B of the Pharmacokinetic and Safety study for CPAT-01D, a cannabis-derived … Continue reading

September 5, 2018 Latest News, News